Jean Chidiac

675 total citations
23 papers, 371 citations indexed

About

Jean Chidiac is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Jean Chidiac has authored 23 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Internal Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Hematology. Recurrent topics in Jean Chidiac's work include Venous Thromboembolism Diagnosis and Management (14 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Jean Chidiac is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (14 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Jean Chidiac collaborates with scholars based in France, United Kingdom and Switzerland. Jean Chidiac's co-authors include Isabelle Mahé, H. L. Helfer, Simon Noble, Jeannette Soria, Massoud Mirshahi, R. Varin, Claudine Soria, Pezhman Mirshahi, Elisabeth Perzborn and Christophe Klein and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jean Chidiac

21 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Chidiac France 11 172 152 72 63 62 23 371
G.-F. von Tempelhoff Germany 9 153 0.9× 99 0.7× 54 0.8× 50 0.8× 53 0.9× 24 366
V. Milesi Italy 2 131 0.8× 77 0.5× 59 0.8× 33 0.5× 43 0.7× 3 252
Feras Abu Saadeh Ireland 11 178 1.0× 100 0.7× 73 1.0× 115 1.8× 65 1.0× 41 483
Andrew McQuillan Australia 10 291 1.7× 237 1.6× 37 0.5× 93 1.5× 90 1.5× 19 571
Julia Calzas Spain 7 118 0.7× 83 0.5× 92 1.3× 20 0.3× 60 1.0× 16 283
Che-Kai Tsao United States 7 125 0.7× 78 0.5× 91 1.3× 84 1.3× 92 1.5× 10 338
J.L. Balibrea Spain 12 201 1.2× 143 0.9× 150 2.1× 113 1.8× 138 2.2× 18 562
Valentina Djordjević Serbia 12 195 1.1× 144 0.9× 27 0.4× 65 1.0× 49 0.8× 47 468
Aurélie Rousseau France 12 116 0.7× 54 0.4× 89 1.2× 72 1.1× 39 0.6× 34 393
Anne O. Rodriguez United States 7 130 0.8× 64 0.4× 130 1.8× 17 0.3× 41 0.7× 8 335

Countries citing papers authored by Jean Chidiac

Since Specialization
Citations

This map shows the geographic impact of Jean Chidiac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Chidiac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Chidiac more than expected).

Fields of papers citing papers by Jean Chidiac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Chidiac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Chidiac. The network helps show where Jean Chidiac may publish in the future.

Co-authorship network of co-authors of Jean Chidiac

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Chidiac. A scholar is included among the top collaborators of Jean Chidiac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Chidiac. Jean Chidiac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahé, Isabelle, et al.. (2025). Cancer-associated thrombosis: what is new?. Current Opinion in Oncology. 37(2). 150–157. 3 indexed citations
2.
3.
Helfer, H. L., et al.. (2023). Diagnostic Approach for Venous Thromboembolism in Cancer Patients. Cancers. 15(11). 3031–3031. 2 indexed citations
4.
Mahé, Isabelle, Isabelle Mahé, Céline Chapelle, et al.. (2020). Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study. Cancers. 12(8). 2256–2256. 18 indexed citations
5.
Mahé, Isabelle, et al.. (2020). Patients experience of living with cancer associated thrombosis in France (Le PELICAN). Thrombosis Research. 194. 66–71. 16 indexed citations
6.
Mahé, Isabelle, et al.. (2019). Patients Experience of Living with Cancer Associated Thrombosis in France (LE PELICAN). Blood. 134(Supplement_1). 3684–3684. 2 indexed citations
7.
Mahé, Isabelle, Y. Benhamou, H. L. Helfer, & Jean Chidiac. (2018). Cancer et récidive thromboembolique veineuse : les clés d’une prise en charge optimale. Bulletin du Cancer. 105(5). 508–516. 1 indexed citations
8.
Mahé, Isabelle, Michele Lamuraglia, Jean Chidiac, et al.. (2016). Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study. Supportive Care in Cancer. 24(8). 3369–3377. 18 indexed citations
9.
Mahé, Isabelle, Jean Chidiac, H. L. Helfer, & Simon Noble. (2016). Factors influencing adherence to clinical guidelines in the management of cancer‐associated thrombosis. Journal of Thrombosis and Haemostasis. 14(11). 2107–2113. 54 indexed citations
10.
11.
12.
Soria, Claudine, G. Kierzek, J.Y. Borg, et al.. (2014). New Combinational Assay Using Soluble Fibrin and D-Dimer Determinations: A Promising Strategy for Identifying Patients with Suspected Venous Thromboembolism. PLoS ONE. 9(3). e92379–e92379. 6 indexed citations
13.
Mahé, Isabelle & Jean Chidiac. (2014). Cancer et récidive thromboembolique veineuse : non-respect des recommandations de traitement. Bulletin du Cancer. 101(3). 295–301. 9 indexed citations
14.
Varin, R., Pezhman Mirshahi, Christophe Klein, et al.. (2013). Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban. Thrombosis Research. 131(3). e100–e109. 73 indexed citations
15.
Emile, George, L. Chauvenet, Jean‐Marie Tigaud, et al.. (2013). A clinical experience of single agent bevacizumab in relapsing ovarian cancer. Gynecologic Oncology. 129(3). 459–462. 17 indexed citations
16.
Camilleri‐Broët, Sophie, Eliane Mery-Lamarche, Hamda Al-Thawadi, et al.. (2012). Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset. International Journal of Oncology. 41(2). 433–440. 30 indexed citations
17.
Friman, Tomas, Renata Gustafsson, Jean Chidiac, et al.. (2012). Increased Fibrosis and Interstitial Fluid Pressure in Two Different Types of Syngeneic Murine Carcinoma Grown in Integrin β3-Subunit Deficient Mice. PLoS ONE. 7(3). e34082–e34082. 14 indexed citations
18.
Mirshahi, Pezhman, Hong Li, Emmanuel Blot, et al.. (2011). Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets. Cancer Letters. 317(2). 207–217. 27 indexed citations
19.
20.
Laurent, Marc, R. Varin, Hong Li, et al.. (2009). A Novel Mechanism of Action of Rivaroxaban: Inhibition of Monocyte and Macrophage Procoagulant Activity and Consequence On Inflammatory Process.. Blood. 114(22). 3124–3124. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G.-F. von Tempelhoff Breakdown of academic impact, for papers by V. Milesi Breakdown of academic impact, for papers by Feras Abu Saadeh Breakdown of academic impact, for papers by Andrew McQuillan Breakdown of academic impact, for papers by Julia Calzas Breakdown of academic impact, for papers by Che-Kai Tsao Breakdown of academic impact, for papers by J.L. Balibrea Breakdown of academic impact, for papers by Valentina Djordjević Breakdown of academic impact, for papers by Aurélie Rousseau Breakdown of academic impact, for papers by Anne O. Rodriguez
Rankless by CCL
2026